|Nemera: Patient focused drug delivery devices
Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology & generics industries.
Because it matters for patients’ health
|Nasal, Buccal and Auricular: Easy use, easy breathe
The number of drugs delivered through the nasal, buccal and auricular route is
Patients need high-performance and reliable spray systems.
Nemera offers various technologies with a full range of pumps & valves platforms.
Advancia®: the new generation nasal pump
Created to improve patient experience and adherence, the Advancia® technology platform is a combination of user-independent & preservative-free features in one single device. It brings together ultimate performance and attractive design.
Advancia® offers a new alternative to improve treatment compliance in an increasingly demanding nasal spray market.
The Advancia® pump technology platform has been completely designed by Nemera to meet regulatory expectations and offer patients a user-friendly nasal spray.
The Advancia® innovative project is cofinanced by the European Union. Europe is committed in Normandy with the European Regional Development Fund (FEDER).
SP270+ / SP370+: Quality and performance for prescription sprays
The SP270+ and SP370+ are our versatile pump platforms for ear, nose and throat spray delivery. Customized versions of the SP270+ are also available with in-vitro bioequivalence performance for the main nasal suspensions.
SP27 / SP37: Quality systems for OTC drugs
Quality and performance for prescription sprays
|Child Resistant Closure : NEW innovative concepts for nasal and dermal pumps
To meet ever increasing regulatory requirements Nemera has developed child resistant closure concepts for nasal and dermal pumps. All concepts have been designed with input from patients to ensure good ergonomics and functionality while maintaining safety for children. They are based on well-known One-Clic and Squeeze and Turn technologies.
|Inhalation: a partner of choice
The pulmonary route is widely used for drugs treating lung diseases but it can also be the pathway for systemic treatments. Consistency and reliability are critical for respiratory patients.
Key players in the pharmaceutical industry have trusted Nemera to develop and industrialize their inhalation devices, from concept generation to large scale manufacturing.
Nemera has a recognized expertise in the development and manufacturing of respiratory drug delivery devices, such as Dry Powder Inhalers (DPIs), pressurized Metered Dose inhalers (pMDIs) and dose counters.
More than ten million asthmatics rely everyday on devices manufactured by Nemera.
20, Avenue de la Gare
38290 La Verpillière
Phone: +33 (0)4 74 94 06 54
Fax: +33 (0) 4 74 94 90 60
Twitter : @Nemera_devices